Tetanus Gamma

Tetanus Gamma

tetanus immunoglobulin


Kedrion S.p.A.


Concise Prescribing Info
Human tetanus Ig
Immediate prophylaxis after tetanus prone injuries in patients not adequately vaccinated; whose immunisation status is not known w/ certainty & w/ severe deficiency in Ab production. Clinically manifest tetanus.
Dosage/Direction for Use
IM Prophylaxis of tetanus prone wounds 250 IU. Dose may be increased to 500 IU in case of infected wounds where surgically appropriate treatment cannot be achieved w/in 24 hr, or deep or contaminated wounds w/ tissue damage & reduced oxygen supply as well as foreign body injury. Therapy of clinically manifesting tetanus Single doses of 3,000-6,000 IU.
Hypersensitivity to human tetanus Ig or human Ig. Do not administer as IV & to individuals w/ Ab against IgA.
Special Precautions
Do not administer into blood vessel (risk of shock). Individuals w/ IgA deficiency. Discontinue if allergic or anaphylactic type reactions occur. May interfere w/ some serological tests for RBCs eg, Coombs' test. Pregnancy & lactation. Childn.
Adverse Reactions
Hypersensitivity, anaphylactic shock; headache; tachycardia; hypotension; nausea, vomiting; skin reaction, erythema, itching, pruritus; arthralgia; fever, malaise, chills; swelling, pain, erythema, induration, warmth, pruritus, rash & itching at inj site.
Drug Interactions
ATC Classification
J06BB02 - tetanus immunoglobulin ; Belongs to the class of specific immunoglobulins. Used in passive immunizations.
Tetanus Gamma vaccine 250 IU/mL
(pre-filled syringe) 1 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in